| dc.contributor.author | Fernandes, Beatriz | |
| dc.contributor.author | Tomás, Maria Teresa | |
| dc.date.accessioned | 2015-08-20T11:19:36Z | |
| dc.date.available | 2015-08-20T11:19:36Z | |
| dc.date.issued | 2015 | |
| dc.description.abstract | Duchenne muscular dystrophy (DMD) is a severe, progressive disease first described by Meryon in 1852 and later by Guillaume Duchene. It is the most common and severe form of childhood muscular dystrophy, affecting 1 in 3500 live male births. Is caused by an X—linked recessive genetic disorder resulting in a deficiency of the dystrophin protein, responsible for linking contractile proteins to the sarcolemma. Diagnosis is not always easy and the first symptoms are often related to weakness and difficulty or delay in acquiring the ability to perform simple activities. Progressive weakness leads to the use of compensatory strategies in order to maintain the ability to walk and perform other activities. Respiratory muscles are also affected and the complications resulting from its impairments are frequently the cause of early death of these patients. The advances in DMD management has increased life expectancy of these children with the need for adequate care in adulthood. DMD manifestations include muscle weakness, contractures, respiratory and cardiac complications. Some authors also refer that one-third of patients have difficulties with learning and delayed global development because the gene that encodes dystrophyn expresses various dystrophin isoforms that are found in Schwann and Purkinje celis in the brain. Body functions and structure impairments like muscle weakness, contractures and reduced range of motion lead to limitations in activities, i.e., impairments affect the performance of tasks by the individual. In a physiotherapist’s point of view analysing these limitations is mandatory because physiotherapy’s final purpose is to restore or preserve the ability to perform ADL and to improve quality of life. | por |
| dc.identifier.citation | Fernandes B, Tomás MT. Physiotherapy and Duchenne muscular dystrophy. In Honório SA, editor. Duchenne muscular dystrophy: symptoms, management and prognosis. New York: Nova Science; 2015. p. 57-80. | por |
| dc.identifier.isbn | 9781634821537 | |
| dc.identifier.uri | http://hdl.handle.net/10400.21/4873 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Nova Science Publishers | por |
| dc.relation.publisherversion | https://www.novapublishers.com/catalog/product_info.php?products_id=53823&osCsid=24d54a59f260dcae85644243806025e0 | por |
| dc.subject | Physiotherapy | por |
| dc.subject | Rehabilitation | por |
| dc.subject | Duchenne muscular dystrophy | por |
| dc.subject | Chronic disease | por |
| dc.subject | Muscle weakness | por |
| dc.subject | Respiratory rnuscles weakness | por |
| dc.subject | Contractures | por |
| dc.title | Physiotherapy and Duchenne muscular dystrophy | por |
| dc.type | book part | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 80 | por |
| oaire.citation.startPage | 57 | por |
| person.familyName | Tomás | |
| person.givenName | Maria Teresa | |
| person.identifier | 438585 | |
| person.identifier.ciencia-id | 3010-19D6-C7A5 | |
| person.identifier.orcid | 0000-0003-0491-8903 | |
| person.identifier.rid | N-1940-2013 | |
| person.identifier.scopus-author-id | 36700434200 | |
| rcaap.rights | restrictedAccess | por |
| rcaap.type | bookPart | por |
| relation.isAuthorOfPublication | 64ad74a4-4cd4-426e-a1ee-2ec846fdc6dd | |
| relation.isAuthorOfPublication.latestForDiscovery | 64ad74a4-4cd4-426e-a1ee-2ec846fdc6dd |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- Physiotherapy and Duchenne muscular dystrophy.pdf
- Size:
- 2.13 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: